Evidence map›Paper›PMID 36706849›Full record

ArticleJournal of biomedical informatics2023

Evaluating and mitigating bias in machine learning models for cardiovascular disease prediction.

Fuchen Li, Patrick Wu, Henry H Ong, Josh F Peterson, Wei-Qi Wei, Juan Zhao

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical informatics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Using Under-Represented Subgroup Fine Tuning to Improve Fairness for Disease Prediction.Biomedical engineering systems and technologies, international joint conference, BIOSTEC ... revised selected papers. BIOSTEC (Conference) · 2025
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Fuchen LiCollege of Art and Science, Vanderbilt University, Nashville, TN, USA.
Patrick WuDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
Henry H OngDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
Josh F PetersonDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
Wei-Qi WeiDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
Juan ZhaoDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: juan.zhao@heart.org.
Vanderbilt University Medical Center · USVanderbilt University · US

Funding

The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Vanderbilt Biomedical Informatics Training ProgramT15LM007450 · NLM · VANDERBILT UNIVERSITY · PI Jessica S. Ancker, Bradley A. Malin · 2002 to 2026
$19.7M
Understanding and preventing HLA-associated drug reactionsP50GM115305 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DENNY, JOSHUA C. · 2015 to 2019
$13.0M
From GWAS to PheWAS: Scanning the EMR Phenome for Gene-disease AssociationsR01LM010685 · NLM · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BASTARACHE, LISA · 2011 to 2022
$6.3M
PheMAP: Measured, Automated Profile to Facilitate High Throughput PhenotypingR01GM139891 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WEI, WEI-QI · 2021 to 2024
$1.7M
Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort - Diversity SupplementR01HL133786 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WEI, WEI-QI · 2017 to 2020
$1.7M
American Heart Association-American Stroke Association 18AMTG34280063NCATS NIH HHS UL1 TR000445NHLBI NIH HHS R01 HL133786NIGMS NIH HHS P50 GM115305NIGMS NIH HHS R01 GM139891NLM NIH HHS R01 LM010685NLM NIH HHS T15 LM007450
6 · The paper itself

Abstract

objectiveThe study aims to investigate whether machine learning-based predictive models for cardiovascular disease (CVD) risk assessment show equivalent performance across demographic groups (such as race and gender) and if bias mitigation methods can reduce any bias present in the models. This is important as systematic bias may be introduced when collecting and preprocessing health data, which could affect the performance of the models on certain demographic sub-cohorts. The study is to investigate this using electronic health records data and various machine learning models.

methodsThe study used large de-identified Electronic Health Records data from Vanderbilt University Medical Center. Machine learning (ML) algorithms including logistic regression, random forest, gradient-boosting trees, and long short-term memory were applied to build multiple predictive models. Model bias and fairness were evaluated using equal opportunity difference (EOD, 0 indicates fairness) and disparate impact (DI, 1 indicates fairness). In our study, we also evaluated the fairness of a non-ML baseline model, the American Heart Association (AHA) Pooled Cohort Risk Equations (PCEs). Moreover, we compared the performance of three different de-biasing methods: removing protected attributes (e.g., race and gender), resampling the imbalanced training dataset by sample size, and resampling by the proportion of people with CVD outcomes.

resultsThe study cohort included 109,490 individuals (mean [SD] age 47.4 [14.7] years; 64.5% female; 86.3% White; 13.7% Black). The experimental results suggested that most ML models had smaller EOD and DI than PCEs. For ML models, the mean EOD ranged from -0.001 to 0.018 and the mean DI ranged from 1.037 to 1.094 across race groups. There was a larger EOD and DI across gender groups, with EOD ranging from 0.131 to 0.136 and DI ranging from 1.535 to 1.587. For debiasing methods, removing protected attributes didn't significantly reduced the bias for most ML models. Resampling by sample size also didn't consistently decrease bias. Resampling by case proportion reduced the EOD and DI for gender groups but slightly reduced accuracy in many cases.

conclusionsAmong the VUMC cohort, both PCEs and ML models were biased against women, suggesting the need to investigate and correct gender disparities in CVD risk prediction. Resampling by proportion reduced the bias for gender groups but not for race groups.

Indexed as

Cardiovascular DiseasesAlgorithmsFemaleHumansLogistic ModelsMachine LearningMaleMiddle AgedRandom ForestBias mitigationCardiovascular diseasesClinical predictive modelsElectronic health recordsFairnessMachine learning

Identifiers

PMID36706849
PMCPMC11104322
OpenAlexW4318393059

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.